{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:22:01Z","timestamp":1793701321211,"version":"4.5.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","award":["2021CXGC010506"],"award-info":[{"award-number":["2021CXGC010506"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270580"],"award-info":[{"award-number":["82270580"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070552"],"award-info":[{"award-number":["82070552"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ijantimicag.2024.107325","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T17:19:55Z","timestamp":1725643195000},"page":"107325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Antibiotic resistance of Helicobacter pylori in Mainland China: A focus on geographic differences through systematic review and meta-analysis"],"prefix":"10.1016","volume":"64","author":[{"given":"Shuyan","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhou","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7042-9695","authenticated-orcid":false,"given":"Yueyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijantimicag.2024.107325_bib0001","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.01.028","article-title":"Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis","volume":"150","author":"Lee","year":"2016","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.ijantimicag.2024.107325_bib0002","doi-asserted-by":"crossref","first-page":"e888","DOI":"10.1016\/S2468-2667(21)00164-X","article-title":"The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study","volume":"6","author":"Yang","year":"2021","journal-title":"Lancet Public Health"},{"issue":"2","key":"10.1016\/j.ijantimicag.2024.107325_bib0003","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.ijantimicag.2024.107325_bib0004","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/gutjnl-2021-325630","article-title":"Chinese consensus report on family-based Helicobacter pylori infection control and management (2021 edition)","volume":"71","author":"Ding","year":"2022","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ijantimicag.2024.107325_bib0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.ijantimicag.2024.107325_bib0006","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ijantimicag.2024.107325_bib0007","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ajg.2016.563","article-title":"ACG clinical guideline: treatment of Helicobacter pylori infection","volume":"112","author":"Chey","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.ijantimicag.2024.107325_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2020-322368","article-title":"Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus","volume":"69","author":"Liou","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ijantimicag.2024.107325_bib0009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","article-title":"The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults","volume":"151","author":"Fallone","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijantimicag.2024.107325_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.ijantimicag.2024.107325_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11070786","article-title":"Primary antibiotic resistance of Helicobacter pylori in different regions of China: a systematic review and meta-analysis","volume":"11","author":"Chen","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.ijantimicag.2024.107325_bib0012","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jgar.2023.05.014","article-title":"Primary antibiotic resistance in Helicobacter pylori in China: a systematic review and meta-analysis","volume":"34","author":"Wang","year":"2023","journal-title":"J Glob Antimicrob Resist"},{"issue":"10","key":"10.1016\/j.ijantimicag.2024.107325_bib0013","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2468-1253(17)30219-4","article-title":"Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis","volume":"2","author":"Kuo","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.ijantimicag.2024.107325_bib0014","article-title":"Antibiotic resistance prevalence and trends in patients infected with Helicobacter pylori in the period 2013-2020: results of the European Registry on H. pylori Management (Hp-EuReg)","volume":"10","author":"Bujanda","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"10.1016\/j.ijantimicag.2024.107325_bib0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2471\/BLT.22.288862","article-title":"Inpatient antibacterial use trends and patterns, China, 2013-2021","volume":"101","author":"Wushouer","year":"2023","journal-title":"Bull World Health Organ"},{"issue":"8","key":"10.1016\/j.ijantimicag.2024.107325_bib0016","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.14309\/ajg.0000000000001828","article-title":"Helicobacter pylori antibiotic resistance in the United States between 2011 and 2021: a systematic review and meta-analysis","volume":"117","author":"Ho","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.ijantimicag.2024.107325_bib0017","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1136\/gutjnl-2015-309900","article-title":"Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy","volume":"64","author":"Zhang","year":"2015","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.ijantimicag.2024.107325_bib0018","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.3748\/wjg.v21.i8.2522","article-title":"Meta-analysis: is combination of tetracycline and amoxicillin suitable for Helicobacter pylori infection?","volume":"21","author":"Lv","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2024.107325_bib0019","article-title":"Effectiveness of Helicobacter pylori treatments according to antibiotic resistance","author":"Bujanda","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.ijantimicag.2024.107325_bib0020","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/1751-2980.12934","article-title":"Susceptibility-guided quadruple therapy is not superior to medication history-guided therapy for the rescue treatment of Helicobacter pylori infection: a randomized controlled trial","volume":"21","author":"Ji","year":"2020","journal-title":"J Dig Dis"},{"issue":"10","key":"10.1016\/j.ijantimicag.2024.107325_bib0021","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1136\/gutjnl-2021-324032","article-title":"Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community","volume":"70","author":"Megraud","year":"2021","journal-title":"Gut"},{"issue":"25","key":"10.1016\/j.ijantimicag.2024.107325_bib0022","doi-asserted-by":"crossref","first-page":"14607","DOI":"10.1073\/pnas.241517298","article-title":"Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori","volume":"98","author":"Bj\u00f6rkholm","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ijantimicag.2024.107325_bib0023","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/gutjnl-2020-321372","article-title":"European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21\u2009533 patients","volume":"70","author":"Nyssen","year":"2021","journal-title":"Gut"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924002413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924002413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T10:54:39Z","timestamp":1730717679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857924002413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0924857924002413"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107325","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic resistance of Helicobacter pylori in Mainland China: A focus on geographic differences through systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107325"}}